Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Phase 2
Recruiting
- Conditions
- Corneal UlcerKeratitis
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Peschke GmbH
- Target Recruit Count
- 488
- Registration Number
- NCT05255016
- Locations
- 🇺🇸
Colorado Eye Consultants, Littleton, Colorado, United States
🇺🇸Gorovoy M.D Eye Specialists, Fort Myers, Florida, United States
🇺🇸Bay Area Eye Institute, Tampa, Florida, United States
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Phase 2
- Conditions
- KeratitisCorneal Ulcer
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Peschke GmbH
- Target Recruit Count
- 468
- Registration Number
- NCT05255107
- Locations
- 🇺🇸
Colorado Eye Consultants, Littleton, Colorado, United States
🇺🇸Gorovoy M.D Eye Specialists, Fort Myers, Florida, United States
🇺🇸Bay Area Eye Institute, Tampa, Florida, United States
News
No news found